Proficio Capital Partners LLC Has $979,000 Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Proficio Capital Partners LLC increased its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 92.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 10,868 shares of the exchange traded fund’s stock after purchasing an additional 5,225 shares during the period. Proficio Capital Partners LLC’s holdings in SPDR S&P Biotech ETF were worth $979,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Addison Advisors LLC boosted its stake in SPDR S&P Biotech ETF by 27.4% in the 4th quarter. Addison Advisors LLC now owns 535 shares of the exchange traded fund’s stock worth $48,000 after purchasing an additional 115 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in SPDR S&P Biotech ETF by 0.6% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 23,873 shares of the exchange traded fund’s stock worth $2,373,000 after buying an additional 148 shares in the last quarter. Invst LLC lifted its position in SPDR S&P Biotech ETF by 6.0% during the 3rd quarter. Invst LLC now owns 2,807 shares of the exchange traded fund’s stock worth $277,000 after buying an additional 160 shares in the last quarter. Beech Hill Advisors Inc. lifted its position in SPDR S&P Biotech ETF by 2.5% during the 4th quarter. Beech Hill Advisors Inc. now owns 6,655 shares of the exchange traded fund’s stock worth $599,000 after buying an additional 162 shares in the last quarter. Finally, Wealth Alliance lifted its position in SPDR S&P Biotech ETF by 4.4% during the 4th quarter. Wealth Alliance now owns 4,083 shares of the exchange traded fund’s stock worth $368,000 after buying an additional 173 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA:XBI opened at $87.12 on Friday. The company’s 50-day moving average price is $89.59 and its two-hundred day moving average price is $94.38. SPDR S&P Biotech ETF has a one year low of $81.14 and a one year high of $105.47. The stock has a market capitalization of $5.65 billion, a PE ratio of 11.47 and a beta of 0.99.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.